TAG
Intranasal Vaccine
Bharat Biotech targets one billion doses of intranasal vaccine annually
IANS -
Bharat Biotech is targeting to make one billion doses of its Covid-19 intranasal vaccine annually while it is on track to achieve one billion...
Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine
IANS -
Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine,...
Bharat Biotech’s intranasal vaccine trials begin in Kanpur, UP
IANS -
The phase 2 trials of India's first intranasal vaccine against Covid, being developed by Bharat Biotech in collaboration with Washington University School of Medicine...